@article{JTD23661,
author = {Keisuke Okamura and Hidenori Urata},
title = {Anticipated expansion of a new approach to treating hypertension without medication by catheter-based renal denervation},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 26},
year = {2018},
keywords = {},
abstract = {The RADIANCE-HTN SOLO trial recently revealed that catheter-based renal denervation (RDN) using endovascular ultrasound could reduce the ambulatory blood pressure (ABP) after 2 months without medications in patients who had combined systolic/diastolic hypertension (HT) (1). Accordingly, RDN is being re-evaluated because of the contrast to the disappointing results of the SYMPLICITY HTN-3 trial (2), which indicated that RDN did not have an antihypertensive effect.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/23661}
}